Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Nano-X Imaging Ltd. (NNOX) Cash Flow Statement

Nano-X Imaging Ltd. (NNOX) generated -$40.8M of operating cash flow over the twelve months to 2026-09-30, spent $4.2M on capital expenditure and had free cash flow of -$45.0M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

NNOXNano-X Imaging Ltd.Follow NNOX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
26.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
19 Nov, in 26 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Sep 26
Trend
Operating cash flow-38.1-43.4-44.8-36.6-40.8-40.8
Capital expenditure23.27.23.32.84.2-4.2
Free cash flow-61.2-50.6-48.1-39.4-45.0-45.0
Stock-based compensation18.818.66.87.34.2—

USD millions · SEC XBRL

Nano-X Imaging Ltd. — questions

What is Nano-X Imaging Ltd.'s operating cash flow?
-$40.8M over the twelve months to 2026-09-30.
How much does Nano-X Imaging Ltd. spend on capital expenditure?
$4.2M over the twelve months to 2026-09-30.
What is Nano-X Imaging Ltd.'s free cash flow?
-$45.0M over the twelve months to 2026-09-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Nano-X Imaging Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.